NCT05498389 2023-06-01
EMB-01 in Combination With Osimertinib in Patients With EGFR Mutant Lung Cancer
Shanghai EpimAb Biotherapeutics Co., Ltd.
Phase 1/2 Unknown
Clinical Trials
6 trialsNCT02504346 2023-03-28
TREM
Oslo University Hospital
Phase 2 Unknown
NCT02736513 2021-09-02
Intracranial Activity of AZD9291 (TAGRISSO) in Advanced EGFRm NSCLC Patients With Asymptomatic Brain Metastases
Soroka University Medical Center
Phase 2 Unknown
NCT04988607 2021-08-03
Osimertinib Plus Bevacizumab in Untreated EGFR Exon21 L858R Mutated NSCLC
Guangdong Association of Clinical Trials
Phase 2 Unknown
NCT03891615 2020-12-16
Niraparib in Combination With Osimertinib in EGFR-Mutated Advanced Lung Cancer
Massachusetts General Hospital
Phase 1 Unknown
NCT03532698 2020-07-23
Combination of Osimertinib and Aspirin to Treat Osimertinib Resistance Non-small Cell Lung Cancer ( NSCLC)
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
Unknown